FDA Inspection 1051382 — Reproductive Care Of Indiana, PC

Reproductive Care Of Indiana, PC — FEI 3007055959

The FDA completed an inspection of Reproductive Care Of Indiana, PC on May 10, 2018 in Carmel, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 10, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Carmel, IN (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.